Safety Study of SYH2072 Tablet in Healthy Adults
This is an early-stage safety study testing a new experimental tablet called SYH2072 in healthy volunteers. Researchers will give increasing doses to understand how safe it is, how your body processes it, and what effects it has.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–55 years old and in generally good health
- Your body mass index (BMI) is between 19–30, and you weigh at least 50 kg (males) or 45 kg (females)
- You have not had major surgery in the past 6 months and don't plan to have any during the study
- You have not taken prescription drugs, over-the-counter drugs, or supplements for at least 28 days before screening
- You do not smoke more than 5 cigarettes per day and are willing to avoid tobacco during the study
- You do not drink alcohol regularly (more than 14 units per week) and can abstain during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.
This early-phase trial tests a new drug, SYH2056, in healthy people to see how safe it is and how the body handles it. The study will also look at how food affects the drug. If you are generally healthy, this could be a way to contribute to medical research.
This trial tests a new medicine called SPH9788 in healthy people to see how the body handles it. Volunteers must be generally healthy and follow lifestyle rules to help researchers understand the drug's safety and effects.
This trial tests an investigational injection called SYH2062 in healthy adults to see if it's safe. It helps researchers understand how the drug affects the body before testing in patients.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.